06-10-2022, 02:29 AM
OptimizeRx Reports First Quarter 2022 Financial Results, Revenue Up 22%, Successfully Completes EvinceMed Acquisition
Read more here
- Revenue Up 22% to $13.7 million on increased average revenue per top 20 pharmaceutical manufacturer client
- Traction with top 20 pharmaceutical manufacturers continues to advance and drive growth
- Cash flow positive from operations of $4.1 million
Read more here